BRAF and FHIT Expression in HCV Related Cirrhosis and Hepatocellular Carcinoma and Their Association With Prognostic Anatomopathological Features

被引:0
|
作者
Vidigal, Paula V.
Osorio, Fernanda M.
Couto, Claudia A.
Garcia, Paula P.
do Carmo, Paula A. Santos
机构
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Mo1048
引用
收藏
页码:S995 / S995
页数:1
相关论文
共 50 条
  • [31] EGF rs4444903 polymorphism is associated with risk of HCV-related cirrhosis and HBV/HCV-related hepatocellular carcinoma
    Jia Wang
    Yanlin Zhong
    Guixia Meng
    International Journal of Clinical Oncology, 2021, 26 : 2053 - 2064
  • [32] Imaging features of microvascular invasion in hepatocellular carcinoma developed after direct-acting antiviral therapy in HCV-related cirrhosis
    Renzulli, Matteo
    Buonfiglioli, Federica
    Conti, Fabio
    Brocchi, Stefano
    Serio, Ilaria
    Foschi, Francesco Giuseppe
    Caraceni, Paolo
    Mazzella, Giuseppe
    Verucchi, Gabriella
    Golfieri, Rita
    Andreone, Pietro
    Brillanti, Stefano
    EUROPEAN RADIOLOGY, 2018, 28 (02) : 506 - 513
  • [33] MICRORNA SIGNATURE OF EARLY-STAGE HEPATOCELLULAR CARCINOMA ARISING IN HCV-RELATED CIRRHOSIS
    Ghittoni, G.
    Veronese, L.
    Viera, F. Torello
    Curti, V.
    Ghitti, M.
    Rosa, L. L.
    Ravetta, V.
    Siciliani, L.
    Rossi, S.
    JOURNAL OF HEPATOLOGY, 2015, 62 : S463 - S464
  • [34] Future trends of HCV-related cirrhosis and hepatocellular carcinoma under the currently available treatments
    Sypsa, V
    Touloumi, G
    Papatheodoridis, GV
    Tassopoulos, NC
    Ketikoglou, I
    Vafiadis, I
    Hatzis, G
    Tsantoulas, D
    Akriviadis, E
    Koutsounas, S
    Hatzakis, A
    JOURNAL OF HEPATOLOGY, 2004, 40 : 84 - 84
  • [35] Increased oxidative stress damage in HCV and alcohol-related liver cirrhosis and hepatocellular carcinoma
    Abonyi, M
    Toth, T
    Taniki, T
    JOURNAL OF HEPATOLOGY, 2003, 38 : 87 - 87
  • [36] Alpha interferon treatment may prevent hepatocellular carcinoma in HCV-related liver cirrhosis
    Mazzella, G
    Accogli, E
    Sottili, S
    Festi, D
    Orsini, M
    Salzetta, A
    Novelli, V
    Cipolla, A
    Fabbri, C
    Pezzoli, A
    Roda, E
    JOURNAL OF HEPATOLOGY, 1996, 24 (02) : 141 - 147
  • [37] Serum VEGF as a Tumor Marker for Patients With HCV-Related Liver Cirrhosis and Hepatocellular Carcinoma
    Mukozu, Takanori
    Nagai, Hidenari
    Kobayashi, Koujirou
    Ogino, Yu
    Matui, Daigo
    Kanekawa, Takenori
    Kogame, Michio
    Takayama, Ryuji
    Kanayama, Masahiro
    Wakui, Noritaka
    Shinohara, Mie
    Shinohara, Masao
    Ishii, Koji
    Igarashi, Yoshinori
    Sumino, Yasukiyo
    GASTROENTEROLOGY, 2012, 142 (05) : S980 - S980
  • [38] LNCRNA H19 Is Increased In Hepatocellular Carcinoma With Underlying Hcv-Related Cirrhosis
    Garcia-Valdecasas, Marta
    Gil-Gomez, Antonio
    Rojas, Angela
    Gallego-Duran, Rocio
    Munoz, Rocio
    Fombuena, Blanca
    Pastor-Ramirez, Helena
    Del Campo, Jose A.
    Vilar-Gomez, Eduardo
    Ampuero, Javier
    Romero-Gomez, Manuel
    HEPATOLOGY, 2016, 64 : 970A - 970A
  • [39] Imaging features of microvascular invasion in hepatocellular carcinoma developed after direct-acting antiviral therapy in HCV-related cirrhosis
    Matteo Renzulli
    Federica Buonfiglioli
    Fabio Conti
    Stefano Brocchi
    Ilaria Serio
    Francesco Giuseppe Foschi
    Paolo Caraceni
    Giuseppe Mazzella
    Gabriella Verucchi
    Rita Golfieri
    Pietro Andreone
    Stefano Brillanti
    European Radiology, 2018, 28 : 506 - 513
  • [40] A variant in myeloperoxidase promoter hastens the emergence of hepatocellular carcinoma in patients with HCV-related cirrhosis
    Nahon, Pierre
    Sutton, Angela
    Rufat, Pierre
    Charnaux, Nathalie
    Mansouri, Abdellah
    Moreau, Richard
    Ganne-Carrie, Nathalie
    Grando-Lemaire, Veronique
    N'Kontchou, Gisele
    Trinchet, Jean-Claude
    Pessayre, Dominique
    Beaugrand, Michel
    JOURNAL OF HEPATOLOGY, 2012, 56 (02) : 426 - 432